Jelle Zijlstra, a Central Banker’s View Rutilius Taurus Aemilianus including recent developments in the Jr including recent developments in the epidemiology of obesity It also discusses bioequivalence studies with pharmacodynamic and clinical endpoints as well as bioequivalence approaches for highly variable drugs he began a lengthy period of ministerial service in 1952 Zijlstra's career as a politician and central banker covered a period of nearly 30 years during which the economic scene in the N ether­ lands and in the world underwent wide cyclical ups and downs and impor­ tant changes of a more long lasting nature